19th June 2019

Blog post from our partners at Avalon Health Economics

Our partners at Avalon Health Economics have published an interesting blog post on the future directions of HEOR in the 2020s.

Read more here

28th May 2019

Acaster Lloyd Consulting poster presentation at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress

Our team, including Director Sarah Acaster and Senior Research Manager Katy Gallop recently conducted a large European qualitative study exploring the psychosocial impact of living with peanut allergy on adults, adolescents, children and caregivers. If you’re going to EAACI you can view the poster of results “Allergy to Peanut ImPacting Emotions And Life (APPEAL) 2: The first European multi-country qualitative evaluation of the impact of living with peanut allergy” in the Late-Breaking Poster Discussion Session on Monday 3rd June.

Read more here

13th May 2019

Acaster Lloyd Consulting Poster presentation at the American Psychiatric Association (APA) Annual Meeting

Acaster Lloyd Consulting, in a team led by director Sarah Acaster, have had the pleasure of working with Sage Therapeutics during their achievement of the first FDA approved treatment for postpartum depression. A fantastic result for the women and their families in this critical population. As part of this work stream, in an effort to relate patient-reported and clinician-reported outcomes, our director, Sarah Acaster, was part of a study team to explore the relationship between the Hamilton Depression Rating Scale (HAM-D) and Edinburgh Post Natal Depression Scale (EPDS). If you’re going to APA next week you can view the related poster: ‘The association between the HAM-D and EPDS in postpartum depression’ in the poster session on Tuesday 21st May ref: P7-092.

Look out for news of further dissemination associated with this work.

2019 Annual Meeting

10th May 2019

Andrew Lloyd co-authors paper on data visualisation techniques in HEOR

A new paper from Andrew Lloyd discusses the opportunities and challenges associated with data visualisation techniques in health economics and outcomes research (HEOR)

The full paper is available here

10th May 2019

Acaster Lloyd Consulting will be at ISPOR in New Orleans

The Acaster Lloyd Consulting team will be at ISPOR in New Orleans from 18th to 22nd May. Please get in touch with Andrew Lloyd (andrew.lloyd@acasterlloyd.com) or Sarah Acaster (sarah.acaster@acasterlloyd.com) if you’d like to set up a meeting, or come to one of our courses/presentations.

ISPOR invitation

24th April 2019

Acaster Lloyd Consulting poster presentation at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Our director Andrew Lloyd and research associate Natalia Piglowska were both part of the study team to develop health-related quality of life weights (utilities) for health states describing different levels of vision loss in individuals with RPE65-Mediated Inherited Retinal Disorder (IRD). If you’re going to ARVO next week, you can view their poster ‘Estimation of Impact of RPE65-Mediated Inherited Retinal Disease on Quality of Life’ in the ‘Patient perspectives and reported outcomes’ session on Wednesday 1st May.

The full paper is available here

12th March 2019

Andrew Lloyd part of a team to publish new ISPOR Good Practices for Outcomes Research Task Force Report

New paper in Value in Health on the identification, review, and use of health state utilities in cost-effectiveness models.

Read the full article here

11th February 2019

ISPOR press release

Press release from ISPOR about a recent themed issue of Value in Health on the latest research from the EuroQol Group. The issue includes an introductory editorial from our director Andrew Lloyd, followed by a series of papers on the EQ5D.

Read the full article here